Myxedema Secondary to Levothyroxine Malabsorption in Newly Diagnosed Celiac Disease
- PMID: 35783876
- PMCID: PMC9242287
- DOI: 10.7759/cureus.25491
Myxedema Secondary to Levothyroxine Malabsorption in Newly Diagnosed Celiac Disease
Abstract
Celiac disease (CD) is an autoimmune disorder that predominantly affects the small intestine and is related to antibodies created against gluten when the substance is ingested. It is uncommon comorbidity in patients with Hashimoto's thyroiditis (HT). Myxedema is a severe form of hypothyroidism that is commonly related to new diagnoses, medication non-compliance, or malabsorption of thyroid supplementation that can have life-threatening associated conditions like heart failure and coma. In this article, we will describe a case of myxedema secondary to levothyroxine malabsorption in the setting of a newly diagnosed CD.
Keywords: celiac disease (ced); celiac disease and thyroid; hashimoto's hypothyroidism; hypothyroid myxedema coma; hashimoto’s thyroiditis.
Copyright © 2022, Wiggins et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Celiac disease detection in hypothyroid patients requiring elevated thyroid supplementation: a prospective cohort study. Zubarik R, Ganguly E, Nathan M, Vecchio J. Eur J Intern Med. 2015;26:825–829. - PubMed
-
- Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Molberg O, Mcadam SN, Körner R, et al. Nat Med. 1998;4:713–717. - PubMed
-
- Celiac disease and hypothyroidism. Collins D, Wilcox R, Nathan M, Zubarik R. Am J Med. 2012;125:278–282. - PubMed
Publication types
LinkOut - more resources
Full Text Sources